Indian lab group Metropolis kicked off its IPO yesterday (Wednesday, April 3). It hopes to raise Rs 1,200 crore ($175m). We speak to an India-based market expert about the move.
LSE-listed Integrated Diagnostics Holdings (IDH) has released its full-year results showing substantial growth in profits, revenue and EBITDA. The lab group, which was brought to IPO by CEO Hend el Sherbini in 2015 and is present in Egypt, Jordan, Sudan and Nigeria, has added an additional 40 branches to its network in the last year, […]
After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models. HBI asks him where the opportunities are and what they look like.
A public consultation on competition in South Africa could lead to a relaxation on external investment in the laboratory market, Healthcare Europa hears.
We map out 2018's international expansion - and retreat - by healthcare operators in one infographic. It reveals clear trends, like; which regions are the most attractive, where sluggish growth is forcing expansion abroad and which sectors are internationalising fastest. But many big players have also cut their losses in foreign markets this year, so was it, on balance, a positive year for proponents of international diversification?
A public consultation on competition in South Africa could lead to a relaxation on external investment in the laboratory market, Healthcare Nova hears.
Universal Health Coverage is one of the UN's Sustainable Development Goals and it's expected to be completed by 2030. But a newly released report argues that a lack of PPPs is stalling that goal. Healthcare Nova looks at the key findings...
German telehealth company Ada claims that introducing new languages on its AI-powered “symptom checker” app will eventually open the market up to an additional 102 million people.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
